Expansion opportunities Mayo Clinic Laboratories is actively expanding its footprint with a new facility in Southaven, Mississippi, signaling ongoing capacity growth and potential for new client partnerships, logistical collaborations, and regional testing access services.

Strategic partnerships Recent collaborations with Karius for metagenomic infectious disease diagnostics and with Predicate AI Labs for sepsis prediction highlight a strong ecosystem approach; this indicates continued opportunities to upsell integrated AI-enabled testing, predictive analytics, and streamlined sample submission.

Advanced testing Launches of whole transcriptome RNA sequencing and a broad test catalog exceed standard offerings, presenting up-sell potential for high-complexity molecular profiling, tumor sequencing, and precision medicine services to hospitals and clinics seeking cutting-edge diagnostics.

Global reach Serving 4.5 million patients worldwide with 24 million tests annually and 3,000+ tests, Mayo Clinic Laboratories has substantial scale and international credibility, creating opportunities to partner with large health systems, academic centers, and multi-site networks seeking proven reference laboratory capabilities.

Technology enablement A robust tech stack including Epic ADT, Apache Airflow, Kubeflow, ServiceNow, and automation/testing tools indicates readiness for digital transformation partnerships, such as seamless order-to-result workflows, data integration projects, and AI-driven test reporting enhancements.